1-4 of 4
Alvin Zipursky
Close
Sort by
Journal Articles

Leukemia-Initiating Cells in Acute Megakaryoblastic Leukemia and Transient Leukemia of Down Syndrome.

Jian Chen, PhD, Yue Li, M.D., Monica Doedens, John E. Dick, Ph.D., Alvin Zipursky, M.D., Johann K. Hitzler, M.D.
Journal: Blood
Blood (2007) 110 (11): 3377.
https://doi.org/10.1182/blood.V110.11.3377.3377
Published: 2007
Journal Articles

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481

Clinical Trials & Observations
Gita V. Massey, Alvin Zipursky, Myron N. Chang, John J. Doyle, Suhail Nasim, Jeffrey W. Taub, Yaddanapudi Ravindranath, Gary Dahl, Howard J. Weinstein
Journal: Blood
Blood (2006) 107 (12): 4606–4613.
https://doi.org/10.1182/blood-2005-06-2448
Published: 2006
Journal Articles

Long-Term Results of a Low-Dose Cytarabine-Based Regimen for the Treatment of Acute Megakaryoblastic Leukemia and Myelodysplastic Syndrome in Children with Down Syndrome.

Johann Hitzler, MD, Ali Al-Ahmari, MD, Niketa Shah, MD, Lillian Sung, MD, PhD, Alvin Zipursky, MD
Journal: Blood
Blood (2005) 106 (11): 4987.
https://doi.org/10.1182/blood.V106.11.4987.4987
Published: 2005
Journal Articles

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

Clinical Trials & Observations Brief Report
Johann K. Hitzler, Joseph Cheung, Yue Li, Stephen W. Scherer, Alvin Zipursky
Journal: Blood
Blood (2003) 101 (11): 4301–4304.
https://doi.org/10.1182/blood-2003-01-0013
Published: 2003